Prescriber's Letter

September 2018 Issue

Be Ready to Prescribe Alternatives to Valsartan

The valsartan recall will continue to raise questions about how to switch to a different ARB or an ACE inhibitor....

Resources

Chart: Comparison of Angiotensin Receptor Blockers (ARBs)
Chart: Angiotensin Receptor Blocker (ARB) Antihypertensive Dose Comparison
Chart: ACE Inhibitor Antihypertensive Dose Comparison

Expect to Hear About Renal Protection With Newer Diabetes Meds

You'll hear buzz about using SGLT2 inhibitors (Jardiance, etc) or GLP-1 agonists (Victoza, etc) for renal protection in type 2 diabetes....

Consider the Pros and Cons of the ACC/AHA CV Risk Estimator

There's increasing debate about how to estimate cardiovascular risk....

Stick With Allopurinol Instead of Febuxostat for Most Chronic Gout Patients

You'll hear about an advocacy group pushing for withdrawal of the gout med febuxostat (Uloric)....

GO TO FULL ISSUE

Editor's Picks

Flooded house

Help Your Patients Get Their Meds During a Disaster

Questions about Cannabidiol (CBD)

PL Voices: Diabetes Meds and Renal Protection

BROWSE MORE RESOURCES

Med Updates

Imvexxy
estradiol
New vaginal insert estrogen formulation for dyspareunia due to menopause.

Zemdri
plazomicin
An aminoglycoside for carbapenem-resistant Enterobacteriaceae.

Aimovig
erenumab-aooe
A calcitonin gene-related peptide receptor antagonist to prevent migraine.

MORE NEW DRUGS

Journal Club

September
The Safety of Febuxostat in Gout Patients with CV Disease
August
The Efficacy of Erenumab for Migraine Prophylaxis
July
The Impact of Aspirin Use on NSAID Safety
MORE JOURNAL CLUB TOPICS

September 2018 Issue

Be Ready to Prescribe Alternatives to Valsartan

Resources

Expect to Hear About Renal Protection With Newer Diabetes Meds

Consider the Pros and Cons of the ACC/AHA CV Risk Estimator

Stick With Allopurinol Instead of Febuxostat for Most Chronic Gout Patients

Editor's Picks

Help Your Patients Get Their Meds During a Disaster

Questions about Cannabidiol (CBD)

PL Voices: Diabetes Meds and Renal Protection

Med Updates

Journal Club

Webinars

Popular Charts

Popular Patient Education Handouts

Popular Practice Toolboxes

September 2018 Issue

Be Ready to Prescribe Alternatives to Valsartan

Resources

Expect to Hear About Renal Protection With Newer Diabetes Meds

Consider the Pros and Cons of the ACC/AHA CV Risk Estimator

Stick With Allopurinol Instead of Febuxostat for Most Chronic Gout Patients

Editor's Picks

Help Your Patients Get Their Meds During a Disaster Questions about Cannabidiol (CBD) PL Voices: Diabetes Meds and Renal Protection

Med Updates

Journal Club

Webinars

Popular Charts

Popular Patient Education Handouts

Popular Practice Toolboxes

Help Your Patients Get Their Meds During a Disaster

Questions about Cannabidiol (CBD)

PL Voices: Diabetes Meds and Renal Protection